Business Segments DaShenLin Pharmaceutical Group Co., Ltd.
Stocks
603233
CNE100002RG2
Drug Retailers
|
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 16.29 CNY | +0.87% |
|
+2.39% | -7.55% |
| 04-24 | Dashenlin Pharma's Q1 Profit Rises 11% | MT |
| 04-24 | Dashenlin Pharma's 2025 Profit Jumps 35%, Revenue Rises 4% | MT |
Sales 2025 by Business Segment
Sales 2025 by Geography
Historical Breakdown of Revenue by Business Segments
: Breakdown by Business Segment
| Fiscal Period: December | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
Retail | 15.28B | 19.24B | 20.49B | 21.91B | 22.35B | |||||
Gross Profit | - | - | - | - | - | |||||
Franchise and Distribution | 1.01B | 1.54B | 3.42B | 3.94B | 4.48B | |||||
Gross Profit | - | - | - | - | - | |||||
Other Operations | 447M | 444M | 589M | 617M | 635M | |||||
Unallocated Other Operations | - | - | - | - | - | |||||
Gross Profit | - | - | - | - | - |
Geographical Revenue Distribution History
| Fiscal Period: December | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
China | 16.76B | 21.25B | 24.53B | 26.5B | 27.5B | |||||
Total Assets | 17.34B | 20.84B | 24.12B | 26.44B | 26.49B | |||||
Interest Expense | -212M | -232M | -239M | -249M | -189M | |||||
Income Tax Expense | 240M | 336M | 397M | 360M | 491M | |||||
D&A | 1.14B | 1.27B | 1.43B | 1.58B | 1.52B | |||||
CAPEX | -1.29B | -1.03B | -1.8B | -1.48B | -486M | |||||
Net Income | 791M | 1.04B | 1.17B | 915M | 1.24B | |||||
EBT | 1.04B | 1.41B | 1.63B | 1.34B | 1.85B | |||||
Operating Income | 1.04B | 1.42B | 1.63B | 1.35B | 1.86B |
Select your edition
All financial news and data tailored to specific country editions
